Sara Mancuso

APN | Nurse Practitioner - Neonatal, Critical Care

Sara Mancuso is a Chicago, Illinois based nurse practitioner who is specialized as Neonatal, Critical Care nurse. Her current practice location is 225 E Chicago Ave, Chicago. Patients can reach her at 312-227-4000. Sara Mancuso is APN with specialization in Neonatal, Critical Care and her NPI number (Unique professional ID assigned by NPPES) is 1356942239.
Sara Mancuso takes care of premature and critically ill newborns in the neonatal intensive care unit (NICU) of a hospital. Neonatal critical care nurses are a vital part of the neonatal care team and knows the basic newborn resuscitation, able to control the newborn's temperature and know how to initiate cardiopulmonary and pulse oximetry monitoring.

Complete Profile:
Sara Mancuso speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Sara Mancuso
Specialization: Neonatal, Critical Care Nurse Practitioner (NNP)
Gender:Female
Credentials: APN
Practice Address:225 E Chicago Ave, Chicago,
Illinois, 60611-2991
Phone:312-227-4000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1356942239
NPI Enumeration Date: 05 Nov, 2020
NPI Last Update On: 05 Nov, 2020

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Sara Mancuso
225 E Chicago Ave,
Chicago, Illinois
Zip: 60611-2991
Phone Number: 312-227-4000
Patients can reach Sara Mancuso at 225 E Chicago Ave, Chicago, Illinois or can call to book an appointment on 312-227-4000.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.